PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsToothache
MeSH D014098 - toothache
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D005157:Facial pain
$
Success rate
D014076:Tooth diseases
0 Companies
0 Drugs
Success rate
D014098: 
Toothache
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaNaproxen Naproxen  1995-02-28   
Glenmark PharmaceuticalsNaproxen Naproxen  2007-03-28   
MylanNaproxen Naproxen  1993-12-21   
Naproxen, Esomeprazole strontium Naproxen Esomeprazole Magnesium  2021-07-20   
PerrigoNaproxen Naproxen  1997-01-13   
Naproxen, Diphenhydramine Naproxen Diphenhydramine  2019-05-10   
Pseudoephedrine, Naproxen Naproxen Pseudoephedrine  2004-03-17   
P&L Developments (PLD)Naproxen, Diphenhydramine Naproxen Diphenhydramine  2019-01-25   
CiplaNaproxen Naproxen  2011-08-24   
SandozNaproxen Naproxen  1993-12-21   
BayerNaproxen, Pseudoephedrine, Diphenhydramine Aleve  1994-01-11   
TakedaNaproxen, Lansoprazole Prevacid Naprapac  2003-11-14   
Aurobindo PharmaNaproxen Naproxen  2001-04-19   
Pseudoephedrine, Naproxen Naproxen Pseudoephedrine  2022-06-01   
Naproxen, Sumatriptan Sumatriptan Naproxen  2018-02-15   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
71%
5/7
Phase 3
63%
5/8
Approved: 4Overall Success rate: 45%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Perrigo
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use